Lateral flow immunoassay using plasmonic scattering
Abstract The lateral flow immunoassay (LFIA) is one of the most successful sensing platforms for real-world point-of-care (POC) testing. However, achieving PCR-level sensitivity without compromising the inherent advantages of LFIA, such as rapid and robust operation, affordability, and naked-eye det...
| Published in: | Nature Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Online Access: | https://doi.org/10.1038/s41467-025-58663-z |
